Matches in Nanopublications for { ?s ?p "[Tyrosine kinase inhibitors (TKIs) of epidermal growth factor receptor (EGFR) were previously the standard first-line treatments for lung cancers with activating EGFR mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP1294988.RAh4U5vcootu4uWdjnSUK1qYxxPopGxUKiV4hcbI716iI130_assertion description "[Tyrosine kinase inhibitors (TKIs) of epidermal growth factor receptor (EGFR) were previously the standard first-line treatments for lung cancers with activating EGFR mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1294988.RAh4U5vcootu4uWdjnSUK1qYxxPopGxUKiV4hcbI716iI130_provenance.
- NP1294990.RAPWq0QxyCSaJF6DwzH0q3pJ_HiMLqiFi6tT_5_4NDE04130_assertion description "[Tyrosine kinase inhibitors (TKIs) of epidermal growth factor receptor (EGFR) were previously the standard first-line treatments for lung cancers with activating EGFR mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1294990.RAPWq0QxyCSaJF6DwzH0q3pJ_HiMLqiFi6tT_5_4NDE04130_provenance.